[Form 4] JOHNSON & JOHNSON Insider Trading Activity

Rhea-AI Filing Summary

Johnson & Johnson executive Vanessa Broadhurst, EVP of Global Corporate Affairs, reported several equity transactions. On February 17, 2026, she completed an open-market sale of 6,197 shares of Common Stock at a weighted average price of $243.39 per share, leaving her with 23,003 shares of common stock held directly.

On February 13 and 15, 2026, previously granted Restricted Share Units (RSUs) and Performance Share Units (PSUs) vested and were converted into common shares, with a portion of those shares withheld to cover tax obligations. The filing also shows new equity awards under Johnson & Johnson’s Long-Term Incentive Plan, including 14,405 employee stock options and additional RSUs that generally vest in three equal annual installments beginning on the first anniversary of their grant dates.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Broadhurst Vanessa

(Last) (First) (Middle)

ONE JOHNSON & JOHNSON PLAZA

(Street)

NEW BRUNSWICK NJ 08933

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
JOHNSON & JOHNSON [ JNJ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Global Corp Affairs

3. Date of Earliest Transaction (Month/Day/Year)
02/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/13/2026		M		408	A	$0(1)	24,002	D
Common Stock	02/13/2026		F		144(2)	D	$244.55	23,858	D
Common Stock	02/13/2026		M		8,594	A	$0(3)	32,452	D
Common Stock	02/13/2026		F		3,748(4)	D	$244.55	28,704	D
Common Stock	02/15/2026		M		492	A	$0(5)	29,196	D
Common Stock	02/15/2026		F		252(2)	D	$243.45	28,944	D
Common Stock	02/15/2026		M		526	A	$0(6)	29,470	D
Common Stock	02/15/2026		F		270(2)	D	$243.45	29,200	D
Common Stock	02/17/2026		S		6,197	D	$243.39(7)	23,003	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Share Units	(1)	02/13/2026		M			408	(1)	(1)	Common Stock	408	$0	0	D
Performance Share Units	(3)	02/13/2026		M			8,594	02/13/2026	(3)	Common Stock	8,594	$0	0	D
Restricted Share Units	(5)	02/15/2026		M			492	(5)	(5)	Common Stock	492	$0	491(8)	D
Restricted Share Units	(6)	02/15/2026		M			526	(6)	(6)	Common Stock	526	$0	1,050(8)	D
Employee Stock Options (Right to Buy)	$243.45	02/15/2026		A		14,405		(9)	02/15/2036	Common Stock	14,405	$0	14,405	D
Restricted Share Units	(10)	02/15/2026		A		1,034		(10)	(10)	Common Stock	1,034	$0	1,034(11)	D

Explanation of Responses:

1. Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

2. Shares withheld for payment of taxes upon vesting of RSUs.

3. Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 13, 2023. The PSUs convert into shares of Common Stock upon vesting.

4. Shares withheld for payment of taxes upon vesting of PSUs.

5. Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

6. Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

7. This transaction was executed in multiple trades at prices ranging from $243.39 to $243.41. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

8. Each Restricted Share Unit represents a contingent right to receive one share of Company Common Stock.

9. Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date.

10. Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

11. Each RSU represents a contingent right to receive one share of Company Common Stock.

Remarks:

	/s/ Joleen Morgan, as attorney-in-fact for Vanessa Broadhurst	02/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.